WHO Reports 40 Percent Jump in Antibiotic-Resistant infections; BU-Based Nonprofit Leads the Fight Back
CARB-X, an antibiotics research accelerator, is helping bring new medicines, vaccines, and tests to clinics […]
Infectious Diseases
Boston University is a world leader in the study of infectious diseases. Our National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national, cutting-edge network of secure facilities researching everything from COVID to the Ebola virus to HIV with the goal of understanding, controlling, and eradicating them.
